Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk National Research Medical Center of the Russian Academy of Sciences
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
University of California, Davis
Replimune Inc.
Carevive Systems, Inc.
University of Pennsylvania
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
AstraZeneca
Amgen
Eli Lilly and Company
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University Health Network, Toronto
Eli Lilly and Company
Stanford University
Varian, a Siemens Healthineers Company
Complement Theory Inc.
City of Hope Medical Center
UNICANCER
Daiichi Sankyo
City of Hope Medical Center
AstraZeneca
SystImmune Inc.
Astellas Pharma Inc
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Pfizer
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
MediLink Therapeutics (Suzhou) Co., Ltd.
Jonsson Comprehensive Cancer Center
Milton S. Hershey Medical Center
Klus Pharma Inc.
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
Cybrexa Therapeutics
University of Colorado, Denver
Carisma Therapeutics Inc
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Baltimore VA Medical Center
NantBioScience, Inc.
Comprehensive Support Project for Oncology Research
NGM Biopharmaceuticals, Inc